Europe: Cross-Country HTA of Gene Therapy Libmeldy Calls For Price Cut
Joint price negotiations for Orchard’s gene therapy Libmeldy could follow outcome of multi-country health technology assessment.

Joint price negotiations for Orchard’s gene therapy Libmeldy could follow outcome of multi-country health technology assessment.